Comprehensive Summary of the Efficacy and Safety of Tofacitinib 5mg Twice Daily in Patients with Rheumatoid Arthritis and an Inadequate Response to Disease-Modifying Antirheumatic Drugs
- Citation:
- Bird, P., W. Bensen, B. El-Zorkany, J. Kaine, B. H. Manapat-Reyes, V. Pascual-Ramos, D. Witcombe, and A. Anisfeld,
"Comprehensive Summary of the Efficacy and Safety of Tofacitinib 5mg Twice Daily in Patients with Rheumatoid Arthritis and an Inadequate Response to Disease-Modifying Antirheumatic Drugs",
ACR CONFEX 2014, Boston Convention and Exhibition Center, 16 November, 2014.
Date Presented:
16 November
